Atlantic Street Capital Announces Acquisition of Brown’s Medical Imaging | To Combine with Prestige Medical Imaging, to Establish the No.2 Presence Nationally in Medical Imaging Distribution

Atlantic Street Capital (“ASC”), a private equity firm targeting entrepreneurial businesses poised for the next level of growth, acquired Brown’s Medical Imaging, the largest independent medical imaging service and solutions provider in the Midwest United States. ASC previously acquired Prestige Medical Imaging (PMI), a leading provider of imaging service and solutions serving the eastern half of the U.S., in 2021.

Founded in 1995 and headquartered in Omaha, NE, Brown’s Medical Imaging is a medical imaging solutions company providing equipment, service, maintenance, services and support to hospitals, physician practices and ambulatory service centers across the Midwest. Key products include a broad suite of medical imaging equipment including X-ray machines, mammography systems, CT scanners, ultrasound machines, MRI systems, and surgical C-arm systems. Customer practice specialties include orthopedics, radiology, pulmonology, veterinary, chiropractic, urology, podiatry, and urgent care centers.

Peter Shabecoff, Managing Partner of ASC, and deal lead said, “Brown’s Medical Imaging is a service-first organization, differentiating itself against competitors that are positioned as sales-first. Brown’s offers deep and differentiated service coverage, providing the flexibility that national competitors are unable to provide, and servicing its customers at the local level. Brown’s are seen as partners, rather than product and service providers. We are excited to begin working with Chad and the team to broaden the company’s geographic footprint and identify select acquisitions to enhance its suite of product and service offerings. The partnership of Brown’s and Prestige will be a national market leader; the combined companies will be uniquely positioned to serve customers across geographies and imaging modalities.”

Chad Brown, President of Brown’s Medical Imaging, commented, “Our business was founded on the basis of providing the highest level of expert service to our local customers – irrespective of size; and for over 28 years we have lived up to that purpose. With the added support of Atlantic Street Capital, who have invested in businesses similar to ours, we will continue to grow while delivering best-in-class radiology solutions and services to new and existing customers.”

Chad will continue to lead the Brown’s business, and with the other key members of the senior management team, has maintained a meaningful ownership position in the business. The team will also work closely with newly appointed ASC Medical Imaging Platform CEO, Larry Hicks, to collaborate, and eventually combine with PMI, to optimize service and sales across a wider geography, modalities, and vendor base.

Hicks commented, “We will ultimately bring PMI and Brown’s together at the appropriate time to create the 2nd largest independent provider of medical imaging service and solutions in the US. In the meantime, we will collaborate to identify key learnings that allow us to provide higher quality service for our customers and optimize our territorial service delivery for efficiency. I am looking forward to working with the talented teams at Brown’s and PMI moving forward.”

ASC’s expertise in the healthcare services sector includes its investments in Renew Digital, a leading provider of refurbished dental imaging equipment and services, as well, it’s proprietary Global Surgical dental microscope business (the leading dental microscope brand in the U.S.); Prescott’s, the leading independent provider of refurbishment, maintenance, repair, and service work for surgical microscopes in both the U.S. and the UK, utilized in hospital operating rooms and ambulatory surgery centers; Aligned Orthopedic, the premier provider of orthopedic services in the greater Washington, D.C. region; BioTouch, a leading provider of mission critical, transportation solutions exclusively focused on the medical laboratory and hospital industry; and Anatomy IT, the leading provider of managed IT services to the healthcare industry in the Eastern United States.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.